All Stories

  1. ASO Visual Abstract: Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through in-Depth Interviews
  2. Building an Effective International Medical Evacuation Program for Ukrainian Patients With Cancer Amid Prolonged Military Conflict
  3. Impact of Various Treatment Modalities on Long-Term Quality of Life in Cervical Cancer Survivors
  4. Impact of Multi-Institutional Enhanced Recovery after Surgery Protocol Implementation on Elective Colorectal Surgery Outcomes
  5. Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through In-Depth Interviews
  6. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) vs. Postoperative Intraperitoneal (IP) Chemotherapy - Impact on Health-Related Quality of Life in Primary Ovarian Cancer Patients after Cytoreductive Surgery
  7. Risk Factors of a Positive Resection Margin in Locoregional Appendix Cancer and Its Impact on Survival: The National Cancer Database Analysis
  8. ASO Author Reflections: Shaping Paraganglioma Management from Operating Rooms to Genetic Labs
  9. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer – the SENTRY clinical trial
  10. Paraaortic Extra-Adrenal Paraganglioma: Challenging Robotic Resection
  11. Building an Efficient Peritoneal Surface Malignancies Program Despite the Lower-Middle–Income Barriers: Ukraine Experience
  12. ASO Visual Abstract: Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix
  13. Collaborative expertise of gynecological and surgical oncologists in managing advanced epithelial ovarian cancer
  14. Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix
  15. ASO Visual Abstract: Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
  16. Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
  17. ASO Author Reflections: Let’s Redouble Efforts to Stop Peritoneal Recurrence in All Types of Appendix Cancer
  18. Risk Factors for COVID-19 Adverse Outcomes in ICU Settings of Various Types Repurposed Hospitals
  19. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma
  20. ASO Visual Abstract: Safety of Nephrectomy Performed During CRS/HIPEC—A Propensity Score-Matched Study
  21. ASO Author Reflections: Should I Stay or Should I Go? Nephrectomy for Complete CRS/HIPEC
  22. Safety of Nephrectomy Performed During CRS/HIPEC: A Propensity Score-Matched Study
  23. Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
  24. ASO Visual Abstract: Systemic Chemotherapy in High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread after Unsuccessful Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
  25. Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC
  26. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix
  27. ASO Visual Abstract: Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix
  28. Aorta Tetrafurcation
  29. Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases
  30. ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC
  31. ASO Visual Abstract: Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy With and Without Diaphragmatic Resection in Patients with Peritoneal Metastases
  32. Delayed genital necrosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with Mitomycin-C
  33. ASO Author Reflections: Pleural Spread of Peritoneal Malignancies: When Heated Chemoperfusion Can Save the Day
  34. Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients
  35. Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies
  36. ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients With Intrapleural Dissemination of Peritoneal Surface Malignancies
  37. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience
  38. Management of Low-Grade Appendiceal Mucinous Neoplasm with Extensive Peritoneal Spread Diagnosed during Pregnancy: Two Case Reports and Literature Review
  39. Diffuse Ectopic Deciduosis Imitating Peritoneal Carcinomatosis with Acute Abdomen Presentation: A Case Report and Literature Review
  40. Pelvic Anastomosis Without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  41. ASO Author Reflections: Not All Low-Grade Appendiceal Mucinous Neoplasm Mucin is Created Equal
  42. Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  43. A Rare Case of Metastatic Heterogeneous Poorly Differentiated Neuroendocrine Carcinoma of Ileum: A Case Report and Literature Review
  44. Soft-Tissue Myoepithelioma of the Retroperitoneal Space Mimicking a Pancreatic Tumor: A Case Report and Literature Review